Small Intestinal Bacterial Overgrowth (SIBO)

2 biomarkers Peer-reviewed

Biomarkers in this category

2 biomarkers · optimal ranges shown

Hydrogen Increase Over Baseline by 90 Minutes – SIBO Breath Test Marker The "Hydrogen increase over baseline by 90 minutes" is a critical marker designed to detect abnormal fermentation in the small intestine. During this test, patients ingest a sugar substrate (typically lactulose), and breath samples are collected over a 2-hour period to measure hydrogen and methane gas levels produced by bacteria. In a healthy digestive tract, minimal hydrogen is produced in the small intestine, as most bacteria reside in the large intestine. However, a rise in hydrogen of ≥20 parts per million (ppm) above baseline within 90 minutes strongly suggests the presence of SIBO, where excess bacteria ferment carbohydrates prematurely in the small intestine—leading to symptoms like: Bloating Abdominal discomfort Excessive gas Diarrhea or loose stools Nutrient malabsorption This marker helps differentiate hydrogen-dominant SIBO from other digestive disorders and guides targeted treatment using antimicrobial herbs, antibiotics, or dietary strategies like the low FODMAP diet. Why It Matters An early hydrogen rise is a hallmark of bacterial overgrowth in the small intestine, not the colon. Identifying this pattern allows clinicians to address the root cause of chronic digestive symptoms, reduce inflammation, restore gut balance, and improve long-term gastrointestinal health.

Peak Methane (CH4) Production – SIBO Breath Test Marker Peak Methane (CH4) Production is a critical marker in NutriPATH’s 2-Hour SIBO Breath Test, used to detect methane-producing microbes in the small intestine, particularly methanogenic archaea such as Methanobrevibacter smithii. Unlike hydrogen, which is produced by bacteria fermenting carbohydrates, methane is formed when certain archaea consume hydrogen and convert it into methane gas. A methane level of ≥10 parts per million (ppm) at any point during the 2-hour breath test is considered a positive result for methane-dominant SIBO or Intestinal Methanogen Overgrowth (IMO). High methane levels are commonly associated with constipation-predominant symptoms, including bloating, abdominal discomfort, slowed motility, and hard stools. Methane has been shown to slow intestinal transit time, making it a key contributor to chronic constipation and related disorders such as IBS-C. Identifying peak methane production helps practitioners tailor treatment strategies using specific antimicrobials or combination therapies targeting methanogens, often requiring different interventions than those used for hydrogen-dominant SIBO. Recognizing elevated methane also supports a more accurate diagnosis and enables effective symptom resolution through personalized gut health protocols.